China Cord Blood reported 160.45M in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Cerus CERS:US $ -11126000 3.28M
China Cord Blood CO:US 160.45M 3.9M
Concord Medical Services Hldg CCM:US -183908000 12.98M
Cytori Therapeutics CYTX:US $ -3499000 924K
Enzo Biochem ENZ:US $ -1.83M 8.75M
Mednax MD:US $ 58.79M 8.78M